Hepatocellular adenoma: Where are we now?

Area of Science:

• Hepatology
• Molecular Pathology
• Oncology

Background:

• Hepatocellular adenoma (HCA) is a benign liver neoplasm predominantly affecting young women, often linked to oral contraceptive use.
• Complications such as hemorrhage and malignant transformation underscore the importance of understanding HCA molecular pathology.
• Recent advancements in molecular studies have significantly enhanced the comprehension of HCA subtypes.

Discussion:

• The classification of HCAs based on phenotype and genotype is crucial for clinical management.
• Identifying high-risk HCA subtypes allows for targeted monitoring and intervention strategies.
• This review synthesizes current knowledge on the clinical, pathological, and molecular characteristics of various HCA subtypes.

Key Insights:

• Molecular signatures are key to understanding Hepatocellular Adenoma (HCA) behavior.
• A robust phenotype-genotype classification system is vital for managing HCA.
• Distinguishing HCA subtypes improves clinical decision-making and patient outcomes.

Outlook:

• Further research into HCA molecular mechanisms will refine diagnostic and therapeutic approaches.
• Continued investigation into genotype-phenotype correlations will enhance risk stratification.
• The evolving understanding of HCA subtypes promises improved patient care and reduced complication rates.